poeder en oplosmiddel voor oplossing voor injectie

DRUG4 trials

Sponsors

Ziekenhuis Aan De Stroom, UZ Leuven, Princess Maxima Center For Pediatric Oncology, Leiden University Medical Center

Conditions

Acute lymphoblastic leukemiaMenière's diseaseOligorecurrent hormone-sensitive prostate cancer patientsProstate cancer

Phase 2

Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (THUNDER): A Two-part Phase 2/3 Trial

RecruitingCTIS2022-501551-90-00

Ziekenhuis Aan De StroomProstate cancer

Start: 2023-12-13Target: 583Updated: 2026-01-23

Phase 3

Interfant-21: International collaborative treatment protocol for infants under one year with KMT2A-rearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia

SuspendedCTIS2022-502503-30-00

Princess Maxima Center For Pediatric OncologyAcute lymphoblastic leukemia

Start: 2022-12-15Target: 206Updated: 2026-01-27

Metastasis-directed therapy for oligorecurrent prostate cancer : A randomized phase III trial.

RecruitingCTIS2022-502373-42-00

UZ LeuvenOligorecurrent hormone-sensitive prostate cancer patients

Start: 2022-04-25Target: 873Updated: 2025-03-31

A multicenter, double-blinded, randomized, placebo-controlled trial to compare the effectiveness of intratympanic injections methylPREDnisolone versus placebo in the treatment of vertigo attacks in MENière’s disease (PREDMEN trial).

RecruitingCTIS2023-503340-13-00

Leiden University Medical CenterMenière's disease

Start: 2023-10-05Target: 148Updated: 2024-11-18

Related Papers

The effectiveness of intratympanic injections with methylPREDnisolon versus placebo in the treatment of vertigo attacks in MENière’s disease (PREDMEN trial): a study protocol for a phase-3 multicentre, double-blinded, randomised, placebo-controlled trial

BMJ Open2024-08-012 citations